#gsk #glaxoSmithkline #blenrep #belantamab #mafodotin #blood-cancer #multiple-myeloma #hematologic-cancer #us-fda #fda-panel #drug-approval #drug-safety #advisory-panel #oncology #cancer-treatment #adverse-event-review
1
0
0
0